Methods for treating disease conditions

DETAILED DESCRIPTION I claim: 1.
A method for curative treatment of a disease condition in cats, dogs horses or cattle as follows: (a) in horses: broken wind, heaves, chronic pulmonary disease, laminitis or sweat itch; (b) in cattle: fog fever, husk, acute bovine pulmonary emphysema, bovine farmer's lung and respiratory diseases due to Respiratory Syncytial Bovine Virus; (c) in cats or dogs: allergic condition produced in response to allergens present in foods or food additives, in therapeutic agents, in parasitic fungi, produced by bacterial or fungal infection, or as a response to inhaled or contact antigens; which method comprises administering an effective amount of an active ingredient having sodium cromoglycate like activity to cattle or to a horse, pig, cat or dog suffering from such a condition.
2.
A method according to claim 1 wherein the active ingredient is a compound of formula I, ##STR2## wherein X is a polymethylene chain containing 3 to 7 carbon atoms inclusive, which chain may be substituted by an --OH group, or a pharmaceutically acceptable salt thereof.
3.
A method according to claim 1, wherein the active ingredient is sodium cromoglycate.
4.
A method according to claim 1, wherein the condition is a pulmonary condition in the horse or in cattle in which allergy or immune reactions play a contributory part.
5.
A method according to claim 1, wherein broken wind, heaves, chronic pulmonary disease, laminitis or sweat itch, is treated in a horse.
6.
A method according to claim 1, wherein fog fever, husk, acute bovine pulmonary emphysema, bovine farmer's lung or a respiratory disease due to Respiratory Syncytial Bovine Virus is treated in cattle.
7.
A method according to claim 1, wherein an allergic condition produced as a response to allergens contained in foods and food additives, in therapeutic agents, in parasitic fungi, produced by bacterial or fungal infection, or as a response to inhaled or contact antigens is treated in a cat or dog.
8.
A method according to claim 1, wherein the active ingredient is administered directly to the respiratory tract, the gut or the skin